Eye-disease focused pharmaceutical company Aerie Pharmaceuticals has appointed a trio of new comers to its commercialisation team.
David Biddell joins the US group as its regional sales director for the southeast region, reporting to Gary Menichini who is currently vice president of sales.
Meanwhile, Shaun Gentry and Erin Horn both join from Novartis as directors of national accounts in the market access group.
They will both report to Dale Seibt, who is vice president of market access for North Carolina-based Aerie.